Paul Brian Little

Title: Paul Brian Little: Innovator in Selective Receptor Agonists

Introduction

Paul Brian Little is a notable inventor based in Hoersholm, Denmark. He has made significant contributions to the field of therapeutic interventions through his innovative work on selective receptor agonists. His research focuses on the Y4 receptor, which plays a crucial role in various health conditions.

Latest Patents

Paul Brian Little holds a patent for "Y4 selective receptor agonists for therapeutic interventions." This patent includes a Y4 receptor agonist peptide selected from a specific group of compounds, including [Ala30]PP, [Thr30]PP, [Asn30]PP, and others. These selective agonists are designed to target the Y4 receptor while minimizing interaction with the Y1 and Y2 receptors. The applications of this invention are particularly relevant in treating obesity, overweight conditions, and gastrointestinal issues such as diarrhea and intestinal hypersecretion. He has 1 patent to his name.

Career Highlights

Paul Brian Little is currently associated with 7tm Pharma A/S, where he continues to advance his research in pharmacology and therapeutic solutions. His work has been instrumental in developing new treatments that address significant health challenges.

Collaborations

Throughout his career, Paul has collaborated with esteemed colleagues, including Thue Schwartz and Lars-Ole Gerlach. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Paul Brian Little's contributions to the field of selective receptor agonists highlight his commitment to advancing therapeutic interventions. His innovative work continues to pave the way for new treatments that can significantly impact public health.